The Immunogenicity of Therapeutic Proteins

February 15, 2002
Fiona Adair

,
Daniel Ozanne

BioPharm International, BioPharm International-02-01-2002, Volume 15, Issue 2
Page Number: 30-36

By Fiona Adair and Daniel Ozanne,Biovation Ltd., pp. 30-36. Immunogenicity is often a barrier to further development of potentially therapeutic proteins. That barrier often remains unknown until late in the development chain. The authors explore various strategies for preventing immunogenicity and for predicting it earlier in the process.